Isbn: 9780367708078 - data science, ai, and machine learning in drug development (19 risultati)

Condizione: As New. Unread book in perfect condition.

Condizione: New.

Condizione: New.

Condizione: New.

Condizione: As New. Unread book in perfect condition.

Condizione: New. 1st edition NO-PA16APR2015-KAP.

Condizione: New.

Condizione: New.

Hardback. Condizione: New. New copy - Usually dispatched within 4 working days.

Condizione: New. In English.

Hardback. Condizione: New. 1st. The confluence of big data, artificial intelligence (AI), and machine learning (ML) has led to a paradigm shift in how innovative medicines are developed and healthcare delivered. To fully capitalize on these technological advances, it is essential to systematically harness data from diverse sources and leverage digital technologies and advanced analytics to enable data-driven decisions. Data science stands at a unique moment of opportunity to lead such a transformative change.Intended to be a single source of information, Data Science, AI, and Machine Learning in Drug Research and Development covers a wide range of topics on the changing landscape of drug R and D, emerging applications of big data, AI and ML in drug development, and the build of robust data science organizations to drive biopharmaceutical digital transformations.FeaturesProvides a comprehensive review of challenges and opportunities as related to the applications of big data, AI, and ML in the entire spectrum of drug R and DDiscusses regulatory developments in leveraging big data and advanced analytics in drug review and approvalOffers a balanced approach to data science organization buildPresents real-world examples of AI-powered solutions to a host of issues in the lifecycle of drug developmentAffords sufficient context for each problem and provides a detailed description of solutions suitable for practitioners with limited data science expertise.…

Hardcover. Condizione: Brand New. 352 pages. 9.19x6.13x0.95 inches. In Stock.

Hardback. Condizione: New. 1st. The confluence of big data, artificial intelligence (AI), and machine learning (ML) has led to a paradigm shift in how innovative medicines are developed and healthcare delivered. To fully capitalize on these technological advances, it is essential to systematically harness data from diverse sources and leverage digital technologies and advanced analytics to enable data-driven decisions. Data science stands at a unique moment of opportunity to lead such a transformative change.Intended to be a single source of information, Data Science, AI, and Machine Learning in Drug Research and Development covers a wide range of topics on the changing landscape of drug R and D, emerging applications of big data, AI and ML in drug development, and the build of robust data science organizations to drive biopharmaceutical digital transformations.FeaturesProvides a comprehensive review of challenges and opportunities as related to the applications of big data, AI, and ML in the entire spectrum of drug R and DDiscusses regulatory developments in leveraging big data and advanced analytics in drug review and approvalOffers a balanced approach to data science organization buildPresents real-world examples of AI-powered solutions to a host of issues in the lifecycle of drug developmentAffords sufficient context for each problem and provides a detailed description of solutions suitable for practitioners with limited data science expertise.…

Hardback. Condizione: New. This item is printed on demand. New copy - Usually dispatched within 5-9 working days.

Gebunden. Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Harry Yang, Ph.D., is the Vice President and Head of Biometrics at Fate Therapeutics. He has 27 years of experience across all aspects of drug R &amp D, from early target discovery, through pre-clinical, clinical, translational science, and CMC p.…

Buch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The confluence of big data, artificial intelligence (AI), and machine learning (ML) has led to a paradigm shift in how innovative medicines are developed and healthcare delivered. To fully capitalize on these technological advances, it is essential to systematically harness data from diverse sources and leverage digital technologies and advanced analytics to enable data-driven decisions. Data science stands at a unique moment of opportunity to lead such a transformative change.Intended to be a single source of information, Data Science, AI, and Machine Learning in Drug Research and Development covers a wide range of topics on the changing landscape of drug R & D, emerging applications of big data, AI and ML in drug development, and the build of robust data science organizations to drive biopharmaceutical digital transformations.FeaturesProvides a comprehensive review of challenges and opportunities as related to the applications of big data, AI, and ML in the entire spectrum of drug R & DDiscusses regulatory developments in leveraging big data and advanced analytics in drug review and approvalOffers a balanced approach to data science organization buildPresents real-world examples of AI-powered solutions to a host of issues in the lifecycle of drug developmentAffords sufficient context for each problem and provides a detailed description of solutions suitable for practitioners with limited data science expertise 336 pp. Englisch.…

HRD. Condizione: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

HRD. Condizione: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

Buch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - The confluence of big data, artificial intelligence (AI), and machine learning (ML) has led to a paradigm shift in how innovative medicines are developed and healthcare delivered. To fully capitalize on these technological advances, it is essential to systematically harness data from diverse sources and leverage digital technologies and advanced analytics to enable data-driven decisions. Data science stands at a unique moment of opportunity to lead such a transformative change.Intended to be a single source of information, Data Science, AI, and Machine Learning in Drug Research and Development covers a wide range of topics on the changing landscape of drug R & D, emerging applications of big data, AI and ML in drug development, and the build of robust data science organizations to drive biopharmaceutical digital transformations.FeaturesProvides a comprehensive review of challenges and opportunities as related to the applications of big data, AI, and ML in the entire spectrum of drug R & DDiscusses regulatory developments in leveraging big data and advanced analytics in drug review and approvalOffers a balanced approach to data science organization buildPresents real-world examples of AI-powered solutions to a host of issues in the lifecycle of drug developmentAffords sufficient context for each problem and provides a detailed description of solutions suitable for practitioners with limited data science expertise.…